200
Participants
Start Date
March 28, 2018
Primary Completion Date
June 28, 2019
Study Completion Date
June 28, 2019
Eribulin Mesylate
Eribulin mesylate IV infusion.
Sir Ganga Ram Hospital, New Delhi
Deep Hospital, Ludhiana
J.K.Cancer Institute, Kanpur
King George's Medical University,(Erstwhile Chhatrapati Shahuji Maharaj Medical University), Lucknow
Ajanta Research Centre, Ajanta Hospital & IVF Centre, Lucknow
Sawai Man Singh Hospital, Jaipur
HEMATO-ONCOLOGY CLINIC Vedanta Institute of Medical Sciences, Ahmedabad
Tata Memorial Hospital Department of Oncology, Mumbai
Lokmanya Hospital, Pune
HCG NCHRI Cancer Centre, Nagpur
MNJ Institute of Oncology and Regional Cancer Centre, Hyderabad
HealthCare Global Enterprises Ltd, Bangalore
Srinivasam Cancer Care Multispecialty Hospitals India Pvt Ltd, Bangalore
KR Hospital Mysore Medical College, Mysore
Nilratan Sircar Medical College and Hospital, Kolkata
Netaji Subhash Chandra Bose Cancer Institute, Kolkata
IPGME&R S.S.K.M Hospital, Kolkata
All India Institute of Medical Sciences, Bhubaneswar
Eisai Inc.
INDUSTRY